AR060039A1 - NEW FORMULATIONS - Google Patents
NEW FORMULATIONSInfo
- Publication number
- AR060039A1 AR060039A1 ARP070101155A ARP070101155A AR060039A1 AR 060039 A1 AR060039 A1 AR 060039A1 AR P070101155 A ARP070101155 A AR P070101155A AR P070101155 A ARP070101155 A AR P070101155A AR 060039 A1 AR060039 A1 AR 060039A1
- Authority
- AR
- Argentina
- Prior art keywords
- formulations
- formula
- biocompatible polymer
- independently
- biocompatible
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000009472 formulation Methods 0.000 abstract 4
- 229920000249 biocompatible polymer Polymers 0.000 abstract 3
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000010419 fine particle Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008249 pharmaceutical aerosol Substances 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
Formulaciones farmacéuticas en aerosol, procesos para su preparacion, su uso en terapia, inhaladores de dosificacion que contienen dichas formulaciones y el uso de polímeros biocompatibles para reducir la variabilidad en la uniformidad de contenido y/o proporcionar una fraccion de partículas finas mejorada en dichas formulaciones. Reivindicacion 1: Una formulacion farmacéuticamente en aerosol que contiene: (i) una cantidad terapéuticamente efectiva de medicamento en partículas de la formula (1) o un solvato de esta; (ii) un propulsor seleccionado del grupo que consiste en 1,1,1,2-tetrafluoroetano o 1,1,1,2,3,3,3,-heptafluoro-n-propano o mezclas de estos; y (iii) un polímero biocompatible que comprende uno o más compuestos de la formula (2). Donde n y m representan independientemente un numero entero de al menos uno y el valor de promedio independiente de n y m en el polímero biocompatible está entre 6 y 25; y cada unidad de la formula (3) se encuentra independientemente en el configuracion D o L.Pharmaceutical aerosol formulations, processes for their preparation, their use in therapy, dosing inhalers containing said formulations and the use of biocompatible polymers to reduce variability in content uniformity and / or provide an improved fine particle fraction in said formulations . Claim 1: A pharmaceutically aerosol formulation containing: (i) a therapeutically effective amount of particulate medicament of the formula (1) or a solvate thereof; (ii) a propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3, -heptafluoro-n-propane or mixtures thereof; and (iii) a biocompatible polymer comprising one or more compounds of the formula (2). Where n and m independently represent an integer of at least one and the independent average value of n and m in the biocompatible polymer is between 6 and 25; and each unit of the formula (3) is independently in the D or L configuration.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78463406P | 2006-03-22 | 2006-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR060039A1 true AR060039A1 (en) | 2008-05-21 |
Family
ID=38523271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070101155A AR060039A1 (en) | 2006-03-22 | 2007-03-21 | NEW FORMULATIONS |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP2012797A2 (en) |
| JP (1) | JP2009530419A (en) |
| KR (1) | KR20080110854A (en) |
| CN (1) | CN101415428A (en) |
| AR (1) | AR060039A1 (en) |
| AU (1) | AU2007226899A1 (en) |
| BR (1) | BRPI0708798A2 (en) |
| CA (1) | CA2646236A1 (en) |
| CR (1) | CR10261A (en) |
| EA (1) | EA200801854A1 (en) |
| IL (1) | IL193723A0 (en) |
| MA (1) | MA30328B1 (en) |
| MX (1) | MX2008011967A (en) |
| NO (1) | NO20083760L (en) |
| PE (1) | PE20080124A1 (en) |
| TW (1) | TW200803870A (en) |
| WO (1) | WO2007109698A2 (en) |
| ZA (1) | ZA200807682B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3578169T (en) | 2009-02-26 | 2024-07-29 | Glaxo Group Ltd | Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU679511B2 (en) * | 1993-03-17 | 1997-07-03 | Minnesota Mining And Manufacturing Company | Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
| KR100889426B1 (en) * | 2000-08-05 | 2009-03-23 | 글락소 그룹 리미티드 | 6.alpha., 9.alpha.-difluoro-17.alpha .- '(2-furanylcarboxyl) oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo as anti-inflammatory -Androst-1,4-diene-17-carbothioic acid S-fluoromethyl ester |
| US6750210B2 (en) * | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
-
2007
- 2007-03-21 JP JP2009501708A patent/JP2009530419A/en active Pending
- 2007-03-21 PE PE2007000310A patent/PE20080124A1/en not_active Application Discontinuation
- 2007-03-21 AU AU2007226899A patent/AU2007226899A1/en not_active Abandoned
- 2007-03-21 EA EA200801854A patent/EA200801854A1/en unknown
- 2007-03-21 MX MX2008011967A patent/MX2008011967A/en not_active Application Discontinuation
- 2007-03-21 KR KR1020087025825A patent/KR20080110854A/en not_active Withdrawn
- 2007-03-21 EP EP07758963A patent/EP2012797A2/en not_active Withdrawn
- 2007-03-21 CN CNA2007800098351A patent/CN101415428A/en active Pending
- 2007-03-21 CA CA002646236A patent/CA2646236A1/en not_active Abandoned
- 2007-03-21 AR ARP070101155A patent/AR060039A1/en not_active Application Discontinuation
- 2007-03-21 BR BRPI0708798-5A patent/BRPI0708798A2/en not_active IP Right Cessation
- 2007-03-21 WO PCT/US2007/064462 patent/WO2007109698A2/en not_active Ceased
- 2007-03-21 TW TW096109797A patent/TW200803870A/en unknown
-
2008
- 2008-08-27 IL IL193723A patent/IL193723A0/en unknown
- 2008-08-28 CR CR10261A patent/CR10261A/en not_active Application Discontinuation
- 2008-09-01 NO NO20083760A patent/NO20083760L/en not_active Application Discontinuation
- 2008-09-05 ZA ZA200807682A patent/ZA200807682B/en unknown
- 2008-10-07 MA MA31274A patent/MA30328B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CR10261A (en) | 2008-11-26 |
| WO2007109698A2 (en) | 2007-09-27 |
| PE20080124A1 (en) | 2008-04-21 |
| BRPI0708798A2 (en) | 2011-06-14 |
| ZA200807682B (en) | 2009-11-25 |
| IL193723A0 (en) | 2009-08-03 |
| EP2012797A2 (en) | 2009-01-14 |
| WO2007109698A3 (en) | 2008-12-18 |
| NO20083760L (en) | 2008-12-17 |
| CA2646236A1 (en) | 2007-09-27 |
| JP2009530419A (en) | 2009-08-27 |
| CN101415428A (en) | 2009-04-22 |
| EA200801854A1 (en) | 2009-04-28 |
| MA30328B1 (en) | 2009-04-01 |
| KR20080110854A (en) | 2008-12-19 |
| TW200803870A (en) | 2008-01-16 |
| AU2007226899A1 (en) | 2007-09-27 |
| MX2008011967A (en) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9916865A (en) | Aerosol pharmaceutical composition containing hfa 227 and hfa 134a | |
| BR0303348A (en) | Aerosol formulations for pulmonary drug delivery to produce systemic effect | |
| WO2004108162A3 (en) | Controlled release pharmaceutical composition | |
| BRPI0412211A (en) | controlled release compositions | |
| AR059350A1 (en) | PHARMACEUTICAL FORMULATION FOR AEROSOLS WITH TWO OR MORE ACTIVE PRINCIPLES AND AT LEAST A TENSIOACTIVE SUBSTANCE | |
| DE60114571D1 (en) | PREPARATIONS WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE | |
| PE20080765A1 (en) | PHARMACEUTICAL DOSAGE FORMS | |
| BRPI0414907A (en) | injectable, oral or topical sustained release pharmaceutical formulations | |
| DE60104399D1 (en) | POWDER FORMULATION FOR INHALATION | |
| NO20062504L (en) | Compositions and dosage forms for improved absorption | |
| CA2359812A1 (en) | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures | |
| AR013506A1 (en) | USE OF A PHARMACEUTICAL COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO BE USED IN THE TREATMENT OF DISEASES OF PULMONARCHRONIC OBSTRUCTION AND OF A KIT INCLUDING FORMOTEROL OR A SALT OR SOLVATE OF THE SAME AND BUDESONIDE | |
| AR045076A1 (en) | COMPOSITION OF FILM THAT DISSOLVES ORALALLY, MULTICOMPONENT FILM THAT DISSOLVES ORALALLY, USE OF THE FILM COMPOSITION AND THE FILM THAT ORALLY DISSOLVES TO PREPARE A MEDICINAL PRODUCT, FORM OF ORAL DOSAGE AND PROCEDURE FOR PREPARATION OF COMPOSITION | |
| AR018891A1 (en) | PRESSURIZED INHALERS OF DOSAGE MEASUREMENT AND PHARMACEUTICAL FORMULATIONS IN AEROSOL | |
| ATE389389T1 (en) | MULTIPLE COATED PHARMACEUTICAL DOSAGE FORM | |
| WO2007121913A3 (en) | Pharmaceutical solution formulations for pressurised metered dose inhalers | |
| MX2008000099A (en) | Modified release pharmaceutical compositions on the basis of two polymers and processes thereof. | |
| MX2007006212A (en) | Oral medicament for the modified release of at least one active principle, in multimicrocapsule form. | |
| WO2010103544A3 (en) | A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants | |
| BRPI0411165A (en) | pharmaceutical composition, dosage unit form and methods for preparing its use | |
| MX2010003923A (en) | Pharmaceutical formulation of valsartan. | |
| CL2007003356A1 (en) | COMPOUNDS DERIVED FROM BENZOPIRAZOLES; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND ANOTHER ACTIVE AGENT; AND ITS USE FOR THE TREATMENT OF ASTHMA, INFLAMMATION, AMONG OTHER DISEASES. | |
| UY29905A1 (en) | PHARMACEUTICAL FORMULATION OF ORAL ABSORPTION AND ITS METHOD OF ADMINISTRATION | |
| PE20240808A1 (en) | COMPOSITIONS, METHODS AND SYSTEMS FOR THE ADMINISTRATION OF DRUGS IN AEROSOL | |
| JO2337B1 (en) | Reconstitutable parenteral composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |